APPLICATIONS PUBLISHED 27 AUGUST 2003
Published: 1-Feb-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Methods and apparatus for making seamless capsules
Warner-Lambert 1337217*
Substituted felbamate derived compounds
University of Virginia Patent Foundation 1337218*
Phase transfer of nanoparticles
Nanosolutions 1337219*
Compsns having comfrey and methods for reducing retinoid-induced skin irritation
Avon Products 1337220*
Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
Fresenius kabi Deutschland 1335236*
Pharmaceutical preparations comprising corticosteroids and anti-infective agents
Chandavarkar, Mohan A; Chandavarkar, Nandan M 1337237*
Generation of therapeutic microfoam
BTG International 1337238*
Particles for use in a pharmaceutical compsn
Vectura 1337239*
Method for making particles for use in a pharmaceutical compsn
Vectura 1337240*
Pharmaceutical compsn for inhalation
Vectura 1337241*
Gene delivery formulations and methods for treatment of ischaemic conditions
Valentis 1337242*
Delayed-release pharmaceutical formulations containing proinsulin C-peptide
Creative Peptides Sweden 1337243*
Controlled release hydrocodone formulations
Euroceltique 1337244*
Coloured gelatin-based formulations and method
Banner Pharmacaps 1337245*
Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
Grunenthal 1337246*
GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
H Lundbeck 1337247*
Methods for treatment of inflammatory diseases
Alwyn Company 1337248*
Compsns and methods for administration of pharmacologically active compounds
American Bioscience 1337249*
Use of P38 inhibitors for the treatment of smoke inhalation
SmithKline Beecham 1337250*
Monocyclic or bicyclic carbocycles and heterocycles as factor XA inhibitors
Bristol-Myers Squibb Pharma Company 1337251*
Methods of use of fluoroquinolone compounds against pathogenic Helicobacter bacteria
SmithKline Beecham 1337252*
Novel compounds
GlaxoSmithKline SpA; Laboratoire GlaxoSmithKline SAS 1337253*
Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
Grunenthal 1337254*
Use of P38 inhibitors for the treatment of inflammation-enhanced cough
SmithKline Beecham 1337255*
Use of thienopyrimidines
Merck Patent 1337256*
Use of neuropeptide-Y antagonists in treatment of alcoholism
The Regents of the University of California 1337257*
Methods for inhibiting proliferation of astrocytes and astrocytic tumour cells and uses thereof
Albert Einstein College of Medicine of Yeshiva University 1337258*
Methylenetetrahydrofolate reductase inhibitors and use thereof
McGill University 1337259*
Preparation for strengthening the immune response in the Waldeyer's Ring and the oronasal mucosa by intranasal administration
DMG Italia Srl 1337260*
Anti-inflammation and healing medicine based on laminarin sulphate
Laboratoires Goemar 1337261*
